Image (77e6adf5 F122 42f1 A683 B8ace5df2a30 01)
Escitalopram Tablet, Film Coated
Product Images NDC 16571-757
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Escitalopram (NDC 16571-757). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (77e6adf5 F122 42f1 A683 B8ace5df2a30 02)
This is a description of a medication called Escitalopram. It is available in tablet form, with each tablet containing 5 mg of escitalopram oxalate. The medication is to be dispensed along with a Medication Guide for each patient. The recommended storage temperature is between 20°C to 25°C, with excursions permitted between 15°C to 30°C. The medication should be dispensed in a tight container. The usual dosage should be determined based on the package insert. The medication was issued in May 2023. It is distributed by Rising Pharma Holdings, Inc. and manufactured by Graviti Pharmaceuticals Pvt. Ltd. in Telangana, India. The provided text also includes some unrelated information, such as license numbers and an unvarnished area measurement.*
Image (77e6adf5 F122 42f1 A683 B8ace5df2a30 03)
Image (77e6adf5 F122 42f1 A683 B8ace5df2a30 04)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
